57547-15-6

Basic information

• Product Name: Benzofuran, 7-bromo-2-methyl-
• Synonyms: 7-Brom-2-methylbenzofuran;7-Bromo-2-methylbenzofuran;7-bromo-2-methyl-1-benzofuran;2-methyl-7-bromobenzofuran
• CAS NO: 57547-15-6
• Molecular Formula: C9H7BrO
• Molecular Weight: 211.058
• Mol File: 57547-15-6.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Benzofuran, 7-bromo-2-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzofuran, 7-bromo-2-methyl-(57547-15-6)
• EPA Substance Registry System: Benzofuran, 7-bromo-2-methyl-(57547-15-6)

Safety Data

• Hazardous Substances Data: 57547-15-6(Hazardous Substances Data)

Upstream product

• 1829-34-1 2-hydroxy-3-bromobenzaldehyde 
• 133720-60-2 7-bromobenzo(b)furan 
• 74-88-4 methyl iodide 
• 95-56-7 2-hydroxybromobenzene 
• 106-96-7 propargyl bromide 
• 99029-93-3 1-bromo-2-(2-bromoallyloxy)benzene 
• 188714-81-0 2-bromo-6-(2-bromoallyl)phenol 
• 38770-76-2 1-bromo-2-(prop-2-yn-1-yloxy)benzene 

Downstream Products

• 1100830-52-1 1-benzyl-3-methyl-4-hydroxy-4-(2-methylbenzofuran-7-yl)piperidine 
• 89228-67-1 2-methyl-7-formyl-benzofuran 
• 188714-85-4 5-[2-(3-Bromo-2-bromomethyl-benzofuran-7-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-83-2 5-[2-(2-Bromomethyl-benzofuran-7-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-84-3 5-[2-(3-Bromo-2-methyl-benzofuran-7-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-82-1 5-[2-(2-Methyl-benzofuran-7-yl)-phenyl]-1-trityl-1H-tetrazole 
• 1829-34-1 2-hydroxy-3-bromobenzaldehyde 

Relevant articles and documents

NOVEL COMPOUNDS AND THEIR USE

The present invention provides compounds of the general formula (I) or a pharmaceutically acceptable prodrugs, salts and/or solvates thereof, wherein LHS is selected from the group consisting of LHSa and LHSb And wherein, the asterisk (*) marks the point of attachment; These compounds exhibit antibacterial activity against Gram-negative and Gram-positive bacteria, especially S. aureus, E. coli, K. pneumoniae and A. baumannii. Pharmaceutical compositions containing these compounds, therapeutic uses thereof and methods for manufacturing the same are also provided.

INFLUENZA VIRUS REPLICATION INHIBITOR AND USES THEREOF

The invention belongs to the field of medicine, and particularly relates to a novel compound as a replication inhibitor of influenza virus and a preparation method thereof, a pharmaceutical composition comprising the compound and use of the compound and pharmaceutical composition thereof in treating influenza. The present invention provides a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, The compound of the present invention can inhibit influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties.

PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES

Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. In th